Rocket


Overview
Financials
News + Filings
Key Docs
Ownership





Income Statement
Cash Flow Statement

Parnell Pharmaceuticals Holdings Ltd (PARN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-16Dec-31-15Dec-31-14Jun-30-14Jun-30-13
   20-F20-F20-F20-F20-F
Revenues  19.013.28.47.59.5
            Revenue growth  44.6%57.5% -20.9% 
Cost of goods sold  41.633.625.324.115.9
Gross profit  -22.6-20.5-17.0-16.6-6.4
            Gross margin  -118.6%-155.4%-203.0%-220.1%-66.6%
EBIT   [+]-22.6-20.5-17.0-16.6-6.4
            EBIT margin  -118.6%-155.4%-203.0%-220.1%-66.6%
Other income (expense), net  22.66.75.62.22.2
Pre-tax income  0.0-13.7-11.4-14.4-4.2
Income taxes  0.00.03.03.0-0.7
            Tax rate      16.2%
Net income  0.00.00.00.00.0
            Net margin  0.0%0.0%0.0%0.0%0.0%
   
Basic EPS  $0.00$0.00$0.00$0.00$0.00
Diluted EPS  $0.00$0.00$0.00$0.00$0.00
   
Shares outstanding (basic)   [+]15,809.313,283.710,867.07,960.77,518.6
Shares outstanding (diluted)   [+]15,809.313,283.710,867.07,960.77,518.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy